Another study by Sircoulomb et al. [47] has identified that amplification of 8p11.23 resulted in over-expression of the ERBB2 gene (an oncogenic tyrosine kinase) in estrogen receptor positive breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.